Diabetologia

11β-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes

T. M. Stulnig, W. Waldhäusl

Birthweight of offspring and paternal insulin resistance and paternal diabetes in late adulthood: cross sectional survey

S. G. Wannamethee, D. A. Lawlor, P. H. Whincup, M. Walker, S. Ebrahim, G. Davey-Smith

Post-prandial triglyceride profile in a population-based sample of Type 2 diabetic patients

C. Iovine, O. Vaccaro, A. Gentile, G. Romano, F. Pisanti, G. Riccardi, A. A. Rivellese

Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes

C. R. Bruce, A. D. Kriketos, G. J. Cooney, J. A. Hawley

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

A. Gastaldelli, E. Ferrannini, Y. Miyazaki, M. Matsuda, R. A. DeFronzo

Metabolic syndrome and renal sodium handling in three ethnic groups living in England

A. Barbato, F. P. Cappuccio, E. J. Folkerd, P. Strazzullo, B. Sampson, D. G. Cook, K. G. M. M. Alberti

Reduction of diet-induced obesity in transgenic mice overexpressing uncoupling protein 3 in skeletal muscle

C. Son, K. Hosoda, K. Ishihara, L. Bevilacqua, H. Masuzaki, T. Fushiki, M. E. Harper, K. Nakao

Stable transplantation results of magnetically retracted islets: a novel method

G. G. M. Pinkse, E. Steenvoorde, S. Hogendoorn, M. Noteborn, O. T. Terpstra, J. A. Bruijn, E. de Heer

Protein expression changes in a cell system of beta-cell maturation reflect an acquired sensitivity to IL-1β

K. Nielsen, T. Sparre, M. R. Larsen, M. Nielsen, S. J. Fey, P. Mose Larsen, P. Roepstorff, J. Nerup, A. E. Karlsen

Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes

Y. Min, K. Ghebremeskel, C. Lowy, B. Thomas, M. A. Crawford

Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in Type 1 diabetic patients

R. Moriya, J. C. Manivel, M. Mauer

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat

B. J. Davis, J. M. Forbes, M. C. Thomas, G. Jerums, W. C. Burns, H. Kawachi, T. J. Allen, M. E. Cooper

The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy

S. Schäfer, W. Linz, H. Vollert, G. Biemer-Daub, H. Rütten, M. Bleich, A. E. Busch

Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes

V. W. Bloks, W. M. Bakker-van Waarde, H. J. Verkade, I. P. Kema, H. Wolters, E. Vink, A. K. Groen, F. Kuipers

Angiotensin AT1 receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodiliation in normotensive diabetic rats

N. Horio, A. C. Clermont, A. Abiko, T. Abiko, B. D. Shoelson, S.-E. Bursell, E. P. Feener

Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes

S. X. Zhang, J. Sima, C. Shao, J. Fant, Y. Chen, B. Rohrer, G. Gao, J-x. Ma

TNF-α acts to prevent occurrence of malformed fetuses in diabetic mice

A. Torchinsky, M. Gongadze, H. Orenstein, S. Savion, A. Fein, V. Toder

—to: Looker HC, Fagot-Campagna A, Gunter EW et al. (2003) Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia 46:766–772

N. Shukla, G. D. Angelini, Jamie Y. Jeremy

To: Krebs M, Brehm A, Krssak M et al. (2003) Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia 46:917–925

S. P. Burns, R. D. Cohen

Authors’ reply

M. Roden, M. Krebs, B. R. Landau

—to: Walter U, Toepfer T, Dittmar KE et al. (2003) Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes. Diabetologia 46:1106–1114

D. W. R. Gray

Ethnicity, body mass index and diabetes

Tsung O. Cheng

Cardiovascular complications in Type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state

C. H. Saely, S. Aczel, T. Marte, P. Langer, H. Drexel

Did the Chernobyl incident cause an increase in Type 1 diabetes mellitus incidence in children and adolescents?

A. Zalutskaya, T. Mokhort, D. Garmaev, S. R. Bornstein

IA-2 is not required for the development of diabetes in NOD mice

A. Kubosaki, J. Miura, Abner L. Notkins

Abnormal ghrelin secretion in new onset childhood Type 1 diabetes

C. Holdstock, J. Ludvigsson, F. A. Karlsson

CD14 triggers autoimmune Type 1 diabetes in the NOD mouse

N. Klöting, I. Klöting, R. S. Jack

Identification of regulatory elements in the human adipose most abundant gene transcript-1 (apM-1) promoter: role of SP1/SP3 and TNF-α as regulatory pathways

N. Barth, T. Langmann, J. Schölmerich, G. Schmitz, A. Schäffler

Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15–34 yrs) in the Diabetes Incidence Study in Sweden (DISS)

H. Borg, H. J. Arnqvist, E. Björk, J. Bolinder, J. W. Eriksson, L. Nyström, J-O. Jeppsson, G. Sundkvist

Soluble adhesion molecules in pre-clinical Type 1 diabetes: a prospective study

A. M. Toivonen, P. Kulmala, K. Savola, H. K. Åkerblom, M. Knip

Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Göttingen minipigs

M. O. Larsen, C. F. Gotfredsen, M. Wilken, R. D. Carr, N. Pørksen, B. Rolin

Erratum to: Characterisation of new KATP-channel mutations associated with congenital hyperinsulinism in the Finnish population

F. Reimann, H. Huopio, M. Dabrowski, P. Proks, F. M. Gribble, M. Laakso, T. Otonkoski, F. M. Ashcroft

EASD News Section January 2004